Alembic Pharmaceuticals Ltd profit up by 48% to Rs. 180 crores in Q-3 FY24

Mumbai, February 5th, 2024: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter and nine months period ended 31st December, 2023. Financial Highlights Net Sales grew 8% to Rs.1631 Crores for the quarter. Net Profit up 48% to Rs.180 Crores from Rs.122 Crores EBITDA up 14% to Rs. 269 Crores. Mr. Shaunak Amin, MD, Alembic Pharmaceuticals Limited said “The India Branded Business was underpinned by a continued incremental improvement in core operations. The Specialty and Animal health

Read more